Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More Is Less?

被引：6
|
作者：
Morand, Eric F. [1 ,2 ]
Golder, Vera [3 ]
机构：
[1] Monash Univ, Sch Clin Sci, Clayton, Vic, Australia
[2] Monash Hlth, Rheumatol, Melbourne, Vic, Australia
[3] Monash Hlth, Melbourne, Vic, Australia
来源：
JOURNAL OF RHEUMATOLOGY | 2019年 / 46卷 / 10期
关键词：
DISEASE-ACTIVITY STATE; RHEUMATOID-ARTHRITIS; REMISSION; RECOMMENDATIONS; SLE;
D O I：
10.3899/jrheum.190223
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1256 / 1258
页数：3
相关论文
共 50 条
  • [21] To target or not to target APRIL in systemic lupus erythematosus: that is the question!
    Morel, Jacques
    Hahne, Michael
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (01)
  • [22] Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
    Golder, Vera
    Kandane-Rathnayake, Rangi
    Huq, Moth
    Nim, Hieu T.
    Louthrenoo, Worawit
    Luo, Shue Fen
    Wu, Yeong-jian Jan
    Lateef, Aisha
    Sockalingam, Sargunan
    Navarra, Sandra, V
    Zamora, Leonid
    Hamijoyo, Laniyati
    Katsumata, Yasuhiro
    Harigai, Masayoshi
    Chan, Madelynn
    O'Neill, Sean
    Goldblatt, Fiona
    Lau, Chak Sing
    Li, Zhan Guo
    Hoi, Alberta
    Nikpour, Mandan
    Morand, Eric F.
    LANCET RHEUMATOLOGY, 2019, 1 (02) : E95 - E102
  • [23] Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis
    Sun, F.
    Zhang, D.
    Wang, H.
    Liu, Z.
    Geng, S.
    Wang, X.
    Li, T.
    Wan, W.
    Lu, L.
    Teng, X.
    Morel, L.
    Ye, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (09) : 1733 - 1737
  • [24] Web-based eHealth Clinical Decision Support System as a tool for the treat-to-target management of patients with systemic lupus erythematosus: development and initial usability evaluation
    Sanchez, Agner Russo Parra
    Grimberg, Max G.
    Hanssen, Myrthe
    Aben, Moon
    Jairth, Elianne
    Dhoeme, Prishent
    Tsang-A-Sjoe, Michel W. P.
    Voskuyl, Alexandre
    Jansen, Hendrik Jan
    van Vollenhoven, Ronald
    BMJ HEALTH & CARE INFORMATICS, 2023, 30 (01)
  • [25] Comparison of two frailty definitions in women with systemic lupus erythematosus
    Lieber, Sarah B.
    Nahid, Musarrat
    Legge, Alexandra
    Rajan, Mangala
    Lipschultz, Robyn A.
    Lin, Myriam
    Reid, M. Carrington
    Mandl, Lisa A.
    RHEUMATOLOGY, 2024, 63 (05) : 1384 - 1390
  • [26] Definitions of remission in systemic lupus erythematosus: a post-hoc analysis of two randomised clinical trials
    Parodis, Ioannis
    Emamikia, Sharzad
    Gomez, Alvaro
    Gentline, Cidem
    Arkema, Elizabeth, V
    Chatzidionysiou, Katerina
    van Vollenhoven, Ronald F.
    LANCET RHEUMATOLOGY, 2019, 1 (03) : E163 - E173
  • [27] Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus
    Chen, M
    Zhao, MH
    Zhang, Y
    Wang, H
    LUPUS, 2004, 13 (08) : 584 - 589
  • [28] Case definitions in Swedish register data to identify systemic lupus erythematosus
    Arkema, Elizabeth V.
    Jonsen, Andreas
    Ronnblom, Lars
    Svenungsson, Elisabet
    Sjowall, Christopher
    Simard, Julia F.
    BMJ OPEN, 2016, 6 (01):
  • [29] Target Therapies in Systemic Lupus Erythematosus: Current State of the Art
    Wiesik-Szewczyk, E.
    Lacki, J. K.
    Feleszko, W.
    Olesinska, M.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (10) : 956 - 965
  • [30] Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort
    Saccon, Francesca
    Zen, Margherita
    Gatto, Mariele
    Margiotta, Domenico Paolo Emanuele
    Afeltra, Antonella
    Ceccarelli, Fulvia
    Conti, Fabrizio
    Bortoluzzi, Alessandra
    Govoni, Marcello
    Frontini, Giulia
    Moroni, Gabriella
    Dall'Ara, Francesca
    Tincani, Angela
    Signorini, Viola
    Mosca, Marta
    Frigo, Anna Chiara
    Iaccarino, Luca
    Doria, Andrea
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 943 - 950
12345